collaborative practice agreement cpa legal document united states establishes legal relationship clinical pharmacists collaborating physicians allows pharmacists participate collaborative drug therapy management cdtm cdtm expansion traditional pharmacist scope practice allowing pharmacistled management drug related problems drps emphasis collaborative interdisciplinary approach pharmacy practice healthcare setting terms cpa decided collaborating pharmacist physician though templates exist online cpas specific patient population interest two parties specific clinical situation disease state andor may outline evidencebased protocol managing drug regimen patients cpa cpas become subject intense debate within pharmacy medical professions cpa referred consult agreement physicianpharmacist agreement standing order protocol physician delegation according healthcare researcher karen e koch first coining term collaborative drug therapy management traced back william zellmers publication american journal healthsystem zellmer advocates use term collaborative drug therapy management instead prescribing arguing make legislation expands authority pharmacists palatable lawmakers physician stakeholders importantly centers discussion pharmacists interested expanding authority improve patient care interdisciplinary modern concept collaborative practice derived part avoid controversial term dependent prescribing term collaborative practice agreement also referred consult agreement collaborative pharmacy practice agreement physicianpharmacist agreement standing order standing protocol physician collaborative practice agreement legal document united states establishes formal relationship pharmacists often clinical pharmacy specialists collaborating physicians purpose establishing legal ethical basis pharmacists participate collaborative drug therapy legal guidance requirements formation cpas established state state federal government approved cpas washington first state pass legislation allowing formal formation cpas washington amended practice pharmacy providing formation collaborative drug therapy agreementscitation needed february states washington dc approved laws allow provision two states allow provision cpas alabama alabama pharmacists hoped see cpa law house bill pass bill introduced alabama house representative ron johnson died medicare part b provide reimbursement pharmacy medically underserved areas enhancement act hr introduced house senate january would allow pharmacists reimbursed medicare part b providing healthcare services federallydefined medically underserved must services pharmacists licensed perform particular state services physicians would reimbursed list us states approved cpas year approved andor later updated february cpas implemented management plethora chronic disease states including diabetes mellitus asthma hypertension evidence suggests cpas resulted beneficial health outcomes patients involved shown pharmacists working providers cpas help deliver higher quality care oncology setting including management antiemetic antivomiting therapy within settings cpas resulted improved attainment goal laboratory values like hemoglobin diabetics improved lung function asthmatics improved blood pressure control people cpas used tools pharmacists better integrate practicing clinicians accountable care organization aco offices alleviate time constraints primary care visits help minimize delays managing patients chronic pharmacists involved cpas may participate clinical services outside traditional scope practice pharmacists notably pharmacists need participate cpas provide many pharmacy practice services already covered traditional scope practice performing medication therapy management providing disease prevention services eg immunizations engaging public health screenings eg screening patients depressive disorders major depressive disorder via administering providing diseasestate specific education eg certified diabetes educator counseling patients information regarding expanded pharmacy services cpa described collaborative drug therapy management cdtma traditional scope practice pharmacists provides legal authority detect drug related problems drps provide suggestions solving drps prescribers physicians pharmacists provide cdtm directly solve drps detect may involve prescribing activities include selecting initiating medications treatment patients diagnosed illnesses outlined cpa discontinuing use prescription overthecounter medications modifying patients drug therapy eg changing strength frequency route drug administration duration therapy evaluating patients response drug therapy may include ordering performing laboratory tests basic metabolic panel continuing drug therapy providing new services may include administering medications especially administered parenterally eg longacting injectable legal provisions cpas vary statebystate basis affects specific services pharmacists allowed perform pursuant cpa well terms arrangement eg requirements cpa renewal wisconsins wisconsin act example described american pharmacists association apha granting expansive powers pharmacists state cpa alaskan cpas may involve multiple pharmacists multiple practitioners eg one pharmacist entering cpa group staff physicians multiple pharmacists entering cpa one physician multiple pharmacists entering cpa multiple pharmacists though principal prescribing practitioner must named cpa must specify disease states medications medication classes pharmacists allowed make decisions well procedureprotocol place making decisions decisions must reviewed least every months together covered entities protocols effective maximum years alaskan cpas allow pharmacists monitor drug therapy pursuant aac includes conducting full patient history measuring vital signs orderingevaluating cpa covered laboratory arizonan cpas apply individual pharmacists practitioners referred providers law providers include physicians registered nurse practitioners cpa must specify disease states medications conditions notifying provider laboratory tests pharmacist order pharmacists may monitor modify patients drug treatment accordance cpa provided provider pharmacist mutual patientpractitioner relationship arkansan cpas apply individual pharmacists practitioners specified practitioners authorized prescribe drugs patients specific disease states pharmacists manage along specified drugs pharmacist may use required pharmacists required document interventions discussion collaborative practitioner must retain records least years date record engage cpas pharmacists must able assess health status patients implement pharmaceutical care plan communicate stakeholders monitor patients progress includes able determine intervene patients drug pharmacists may receive credentials organizations board pharmacy october ca governor jerry brown signed senate bill elevates pharmacists role healthcare provider status granting authority provide hormonal contraceptives nicotine replacement vaccinations including travel vaccinations require diagnosis recommended cdc medication recommendations order interpret lab tests optimize drug bill also included classification advanced practice pharmacist aph defined california state board pharmacy licensed pharmacist must satisfy two following licensed board pharmacy aphs perform patient assessments refer patients providers work healthcare providers help manage patients disease states optimizing drug therapies includes initiating adjusting discontinuing medications per protocol established specific organization working aph certification good years long pharmacists license active pharmacist must complete least additional hours continuing education every cpa records must kept minimum years though drug therapy management actions must kept minimum certification renewed biennially completion twenty hours accreditation council pharmacy education acpe category american medical association ama approved continuing ppac certified pharmacist clinician permitted register personal drug enforcement administration dea number scope practice mainly drug therapy related general medicine currently prescriptive authority three types disease states hypercholesterolemia diabetes hypertension within specific disease management pharmacist must meet follow criteria eligible collaborative practice agreement cpp prescriptive powers controlled noncontrolled pharmacists help physicians manage ambulatory patients chronic diseases variety registration cpp designation must renewed annually require hours continuing education cpas focus advocacy efforts professional pharmacy organizations january american pharmacists association apha convened consortium composed pharmacy medicine nursing stakeholders representing states discuss integration cpas everyday clinical consortium published white paper titled consortium recommendations advancing pharmacists patient care services collaborative practice agreements summarizing july national alliance state pharmacy associations naspa convened working group composed appointees ceos joint commission pharmacy practitioners jcpp member organizations national association chain drug stores individual member working groups report made recommendations towards state lawmakers include cpa american college clinical pharmacy accp published updated white paper subject collaborative drug therapy management accp periodically publishes updates subject previous publications paper describes recent history cpas legislative progress discusses payment models collaborative drug therapy management cpas met mixed reviews physicians physician advocacy groups commentary american college clinical pharmacy accp healthcare policy consultant physician terry mcinnis stressed need collaboration improve positive patient outcomes decrease healthcare costs final paragraph makes appeal towards pharmacists interested pursuing cpas pharmacists believe come one rare crossroads define future profession either take place providers care numbers dwindle dispensing activities replaced robotics pharmacy technicians physician say profession patients serve need team clinical pharmacist practitioners truly join keynote address apha annual meeting reid blackwelder president american academy family physicians advocated collaborative view health aafp produced position paper expressed support stressed risk fragmenting care pharmacists given fully autonomous prescribing american medical association ama published series reports called ama scope practice data one reports focused profession pharmacy criticized formation cpas attempt encroach upon physicians scope practice pharmacists response report collaboration seven national professional pharmacy associations drafted response amas report response urged ama correct report publish revised report house delegates ama adopted softer tone apha response input professional pharmacy associations ultimately passing following resolution refocused attention opposing independent rather collaborative dependent practice agreements ama develop model state legislation address expansion pharmacist scope practice found inappropriate constitutes practice medicine including limited issue interpretations usage independent practice arrangements without appropriate physician supervision work interested states specialties advance legislation directive take